Ulcerative Colitis Epidemiology Analysis and Forecast to 2031
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Ulcerative Colitis Market Report Overview
In the 8MM, there were 1,946,428 diagnosed prevalent cases of Ulcerative Colitis (UC) in 2021. The cases are expected to achieve an AGR of less than 1% during the period 2021-2031. Of the 8MM, Canada is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031, and Italy will have the lowest increase in the number of diagnosed prevalent cases. Any change in the diagnosed prevalent cases of UC is attributable to the changing prevalence rates and regression trend analysis in the US, France, Spain, the UK, and Japan as well as the changing population demographics in the 8MM.
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation and ulcers (sores) in the large intestine, also called the colon and rectum. The inflammation usually begins in the rectum and lower colon, but may also spread continuously to involve the entire colon.
The Ulcerative Colitis market research report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for UC in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada). The report also includes a 10-year epidemiology forecast for the diagnosed incident cases and diagnosed prevalent cases of UC.
Ulcerative Colitis Market Outlook, 2021-2031 (Diagnosed Prevalent Cases)
For more insights into the Ulcerative Colitis market forecast, download a free report sample
Ulcerative Colitis Market Segmentation by Age
Depending on age, the UC market can be segmented into 0-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years or above.
In 2021, for the 8MM combined, adults aged 50–59 years contributed the highest proportion of the diagnosed prevalent cases of UC, followed by the age group 60–69 years.
Ulcerative Colitis Market Analysis, by Age, 2021 (%)
For more age insights into the Ulcerative Colitis market, download a free report sample
Ulcerative Colitis Market Segmentation by Sex
Based on sex, the UC market can be segmented into men and women.
In the 8MM, the number of diagnosed prevalent cases of UC was higher in men than in women combined.
Ulcerative Colitis Market Analysis, by Sex, 2021 (%)
For more sex insights into the Ulcerative Colitis market, download a free report sample
Ulcerative Colitis Market Report Overview
Market Size (2021) | 1,946,428 cases |
AGR (2021 – 2031) | <1% |
Key Age Segments | 0-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years or above |
Key Sex Segments | Men and Women |
Segments Covered in the Report
Ulcerative Colitis Market Age Segments Outlook (Diagnosed Prevalent Cases, 2021-2031)
- 0-9 years
- 10-19 years
- 20-29 years
- 30-39 years
- 40-49 years
- 50-59 years
- 60-69 years
- 70-79 years
- 80 years or above
Ulcerative Colitis Market Sex Segments Outlook (Diagnosed Prevalent Cases, 2021-2031)
- Men
- Women
Scope
- The diagnosed incident cases and diagnosed prevalent cases of UC are segmented by age (for all ages in 10-year age groups for ages 0–9 years up to 80 years and older), and sex. The diagnosed prevalent cases of UC are also segmented by severity (mild-moderate, moderate-severe, and severe-fulminant) and anti-tumor necrosis factor (TNF)-responsiveness (TNF-responding, and TNF-non-responding). The report also provides the proportion of diagnosed prevalent cases of UC that develop pouchitis and post-operative UC. The model associated with the report additionally provides the total prevalent cases of UC segmented by age (for all ages) and sex.
- This epidemiology forecast for UC is supported by historical data obtained from peer-reviewed articles and population-based studies. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast incident and prevalent cases of UC across these markets.
Reasons to Buy
The UC epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global UC market.
- Quantify patient populations in the global UC market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for UC therapeutics in each of the markets covered.
Table of Contents
Frequently asked questions
-
How many diagnosed prevalent cases of Ulcerative Colitis (UC) were seen in the 7MM in 2021?
In 2021, 1,946,428 diagnosed prevalent cases of Ulcerative Colitis (UC) were seen in the eight major markets (8MM).
-
What is the growth rate of the Ulcerative Colitis (UC) market?
The cases are expected to achieve an AGR of less than 1% during the period 2021-2031.
-
Which country among the 8MM, is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031?
Of the 8MM, Canada is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031.
-
What are the key age segments in the Ulcerative Colitis (UC) market?
The key age segments in the Ulcerative Colitis (UC) market are 0-9 years, 10-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years or above.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Ulcerative Colitis reports

